NCT00350662View on ClinicalTrials.gov

Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 31, 2002

Conditions
Hemochromatosis
Interventions
DRUG

Deferiprone (L1)

75 mg/kg body weight daily

DRUG

Desferrioxamine

In combination with deferiprone: 40-50 mg/kg body weight 2-times weekly As single agent: 40-50 mg/kg body weight 5- to 7-times weekly

Trial Locations (2)

35100

EGE University Medical School, Bornova, Izmir

Unknown

Pediatric Hospital, Cairo University, Cairo

Sponsors

Lead Sponsor

Lipomed
All Listed Sponsors
lead

Lipomed

INDUSTRY